Clinical trial
Pentoxifylline in Children With Malaria
NCT00133393 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00133393 |
|---|---|
| Title | Pentoxifylline in Children With Malaria |
| Official title | Dose Finding Study of Pentoxifylline in Children With Cerebral Malaria |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Plasmodium Falciparum Malaria |
| Intervention type | Drug |
| Interventions | Pentoxifylline |
| Enrollment | 50 |
| Start date | Jan 1, 2002 |
| Completion | Jul 1, 2005 |
| First posted | Aug 23, 2005 |
| Last update posted | Aug 27, 2010 |
| Countries | Kenya |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: